About this trial
Observational, multicenter, national, cross-sectional study aiming to describe the epidemiological clinical, biological and therapeutic profile of patients suffering from defect in secretion (hypoparathyroidism) or action (pseudo-hypoparathyroidism) of parathyroid hormone.
Eligibility criteria
Qualifiers
Hypoparathyroidism defined by low serum calcium < 2.2 mmol/l (< 88 mg/l) associated with inadequate PTH (low or normal) and normal creatinine
Disqualifiers
Cervical surgery < 6 months.
Transient (neonatal, etc.) or functional (dysmagnesemia, etc.) hypoparathyroidism.
Other causes of hypocalcemia: vitamin D deficiency, chronic renal failure, etc.
Familial hypocalcemia hypercalciuria.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Dacima Consulting
Lead sponsor
Société Tunisienne D'endocrinologie De Diabétologie Et Des Maladies Métaboliques
Collaborator